These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36762206)

  • 21. Molecular Modeling Studies of Novel Fluoroquinolone Molecules.
    Allaka TR; Katari NK; Veeramreddy V; Anireddy JS
    Curr Drug Discov Technol; 2018; 15(2):109-122. PubMed ID: 28875852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
    Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
    ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A ¹¹C-labeled 1,4-dihydroquinoline derivative as a potential PET tracer for imaging of redox status in mouse brain.
    Okamura T; Okada M; Kikuchi T; Wakizaka H; Zhang MR
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):1930-6. PubMed ID: 26082015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases.
    Singh J; Dobrusin EM; Fry DW; Haske T; Whitty A; McNamara DJ
    J Med Chem; 1997 Mar; 40(7):1130-5. PubMed ID: 9089334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10-2474.
    Cerqueira NMFSA; Neves M; Rocha J; Soares-da Silva P; Palma PN
    Chembiochem; 2022 Oct; 23(20):e202200166. PubMed ID: 35843872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of site-directed irreversible folate analogue inhibitors of thymidylate synthase.
    Lobo AP; Nair MG; Changchien L; Weichsel A; Montfort WR; Maley F
    Biochemistry; 1998 Mar; 37(13):4535-42. PubMed ID: 9521774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the 3-dehydroquinase domain of the pentafunctional AROM protein, and the quinate dehydrogenase from Aspergillus nidulans, and the overproduction of the type II 3-dehydroquinase from neurospora crassa.
    Hawkins AR; Moore JD; Adeokun AM
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):451-7. PubMed ID: 8257437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible ligands as probes for drug receptors.
    Newman AH
    NIDA Res Monogr; 1991; 112():256-83. PubMed ID: 1661379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies.
    Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C
    ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism.
    Silva JRA; Cianni L; Araujo D; Batista PHJ; de Vita D; Rosini F; Leitão A; Lameira J; Montanari CA
    J Chem Inf Model; 2020 Mar; 60(3):1666-1677. PubMed ID: 32126170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations.
    Mons E; Roet S; Kim RQ; Mulder MPC
    Curr Protoc; 2022 Jun; 2(6):e419. PubMed ID: 35671150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.
    Honma T; Yoshizumi T; Hashimoto N; Hayashi K; Kawanishi N; Fukasawa K; Takaki T; Ikeura C; Ikuta M; Suzuki-Takahashi I; Hayama T; Nishimura S; Morishima H
    J Med Chem; 2001 Dec; 44(26):4628-40. PubMed ID: 11741480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O'-(epoxyalkyl)tyrosines and (epoxyalkyl)phenylalanine as irreversible inactivators of serine proteases: synthesis and inhibition mechanism.
    Tous G; Bush A; Tous A; Jordan F
    J Med Chem; 1990 Jun; 33(6):1620-34. PubMed ID: 2187995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening, synthesis, crystal structure, and molecular basis of 6-amino-4-phenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles as novel AKR1C3 inhibitors.
    Zheng X; Jiang Z; Li X; Zhang C; Li Z; Wu Y; Wang X; Zhang C; Luo HB; Xu J; Wu D
    Bioorg Med Chem; 2018 Dec; 26(22):5934-5943. PubMed ID: 30429100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amythiamicin D and related thiopeptides as inhibitors of the bacterial elongation factor EF-Tu: modification of the amino acid at carbon atom C2 of ring C dramatically influences activity.
    Gross S; Nguyen F; Bierschenk M; Sohmen D; Menzel T; Antes I; Wilson DN; Bach T
    ChemMedChem; 2013 Dec; 8(12):1954-62. PubMed ID: 24106106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designed mono- and di-covalent inhibitors trap modeled functional motions for Trypanosoma cruzi proline racemase in crystallography.
    Amaral PA; Autheman D; de Melo GD; Gouault N; Cupif JF; Goyard S; Dutra P; Coatnoan N; Cosson A; Monet D; Saul F; Haouz A; Uriac P; Blondel A; Minoprio P
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006853. PubMed ID: 30372428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic basis of the inhibition of type II dehydroquinase by (2S)- and (2R)-2-benzyl-3-dehydroquinic acids.
    Lence E; Tizón L; Otero JM; Peón A; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; González-Bello C
    ACS Chem Biol; 2013 Mar; 8(3):568-77. PubMed ID: 23198883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.